Ultrasonographic Evaluation of Cardiovascular and Fatty Liver Diseases in Type 2 Diabetic Patients: A Prospective and Observational Study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 6, Pages 1208-1212
AbstractAim: Using ultrasound to examine individuals with type 2 diabetes having fatty liver disease and cardiovascular diseases.
Methods: The prospective and observational study was carried out during a nine-month period in the Radiology Department of the MGM Medical College, Kishanganj, Bihar. A total of 300 patients with type 2 diabetes who had abdominal ultrasonography that revealed no other co-morbid conditions and fatty alterations in the liver were included. According to how long the patients had been diagnosed with diabetes, the patients were separated into three groups. Interview schedule questionnaire, OPD records, bedside tickets, physical examination, and laboratory measures made up the study's methodology.
Results: 145 (48.3%) of the 300 patients were men, and 155 (51.7%) were women. The majority (39%) of the patients were between the ages of 50 and 60, while 25.7% of them were between the ages of 40 and 50. 18.3% of the population was between 60 and 70 years old, 10.7% was under 40, and 6.3% was older than 70. 75 (25%) of the 300 cases had non-fatty liver, while 225 (75%) of the cases had fatty liver. 33.4% (100) of the patients who were included belonged to group A, 40% (120) to group B, and 26.6% (80) to group C. The majority of patients (230, 76.7%) did not show ischemia alterations, however 70 (23.3%) cases out of 300 patients did.
Conclusion: Every patient with newly diagnosed type 2 diabetes should consider having a liver ultrasound because NAFLD is particularly common in this population of patients. It may be claimed that in those with type 2 diabetes, there was a correlation between cardiovascular risk factors and NAFLD.
- Article View: 38
- PDF Download: 35